Scope and Purpose:
The Journal of Psychosomatic Obstetrics and Gynecology will bring together information in the field of Psychosomatic Medicine related to Obstetrics and Gynecology. It is intended to provide a forum for the many disciplines involved such as Ethology, Gynecology, Gynecological Oncology, Nursing and Nurse Midwifery, Obstetrics, Perinatology, Psychiatry, Psychology and Reproductive Endocrinology, and will therefore publish clinical and basic information of multidisciplinary interest.
Types of papers:
1. Full Length Papers. Full length papers up to 3500 words, tables and figures excluded, reporting original results within the field of Psychosomatic Obstetrics and Gynecology. These may include critical reviews, clinical reports, theoretical contributions and papers on methodology and treatment.
2. Short Communications. Short communications of up to 1500 words or equivalent space in tables and illustrations. It is expected that these papers will be published in the next available issue.
3. Letters to the Editor. A letter to the editor is supposed to be a comprehensive statement, raising awareness or discussion on a specific topic. This is usually done by:
i) providing one or two examples (cases) a short description of the (social) context,
ii) making clear why this topic is important and relevant for the reader a call for attention,
iii) discussion and/or research in order to put this topic on the professional map.
The Editor reserves the right to abbreviate letters where appropriate.
4. Correspondence. We welcome correspondence related to previously published articles in the Journal of Psychosomatic Obstetrics and Gynecology.
- Correspondence articles to be considered for publication in the Journal must reach us within 8 weeks of publication of the original item and should be no longer than about 600 words.
- Correspondence articles of general interest, unrelated to previously published articles in the journal, are also considered, and can be up to 800 words long.
- Correspondence articles are not usually peer reviewed but the journal may invite replies from the authors of the original publication, or pass on letters to these authors.
- All are edited and proof-queries will be sent out before publication. The corresponding author's signature is taken to be a signature provided on behalf of all authors.
- Correspondence can be sent by mail or by email; a recent email address is necessary.
- Submissions should be sent to Astrid Pascal, Managing Editor JPOG. Please refer to Submission of Manuscripts for further details.
5. Announcements, Book Reviews and Opinions are invited, but will be published at the Editor's discretion.
Copyright:
It is a condition of publication that authors vest or license copyright in their articles, including abstracts, in Informa UK Ltd or the named Society, Association, body or person that holds the copyright. This enables us to ensure full copyright protection and to disseminate the article, and the journal, to the widest possible readership in print and electronic formats as appropriate. All material should conform to the uniform requirements for manuscripts submitted to biomedical journals (Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. Ann Intern Med 1997;126:36-47). Authors submitting reports of randomized clinical trials should ensure that their report conforms with the CONSORT Statement (http://www.consort-statement.org; The Revised CONSORT Statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94). Authors will normally be entitled to publish any part of their paper elsewhere provided permission is requested and the usual acknowledgements are given. The assignment of the copyright will not affect subsisting patent rights or arrangements relating to them. Illustrations, tables or quotations from other publications are already copyrighted and can be reproduced only with written permission from the copyright owner. Written permission to use these should accompany the manuscript.
Advertisements:
Rates are available from the Publisher upon request. The publishers reserve the right to refuse publication.
Ethical review:
The Editor and Publishers support the principles of the Declaration of Helsinki, and expect that the authors of papers submitted to the Journal will have obtained ethical consent and followed those legal and regulatory requirements for human experimentation with drugs, including informed consent, according to procedures which apply in their institution and country.
Authority and responsibility:
The intellectual content of the paper is the responsibility of the authors. The Editor and the Publishers accept no responsibility for opinions and statements of authors. While every effort will be made by the Editor and Publishers to avoid inaccurate and misleading data, they accept no liability whatsoever for the consequences of wrong information. The authors undertake to keep the Editor and the Publishers fully and effectually indemnified against any liability or claims that may arise out of the publication of inaccurate and/or misleading data.
Submission of manuscripts:
All submissions should be made online at The Journal of Psychosomatic Obstetrics and Gynecology's Manuscript Central site. New users should first create an account. Once a user is logged onto the site submissions should be made via the Author Centre.
Authors should prepare and upload an anonymous complete text with all document information identifying the author(s) removed from files to allow them to be sent anonymously to reviewers. When uploading files authors will be able to define the anonymous manuscript as 'Main document' and upload a separate title page, designated as 'Title Page (not for review)'.
Managing Editor Bettina Hosenfeld,
9713 GZ Groningen
PO Box 30 001
9700 RB Groningen
The Netherlands
Phone: + 31 50 361 3001
Fax: +3150 361 1694
Presentation:
Manuscripts should be typed, double spaced, leaving a 5 cm margin at the top and left-hand side of the sheet. Papers should be structured into headed sections as follows: Title page, Abstract, Introduction, Methods, Results, Discussion, Acknowledgements, and References. Authors should also include 2-3 bullet points of appropriate information, under each of the two headings 'current knowledge on this subject' and 'what this study adds' at the end of their manuscript. Each section should begin on a new page and be identified with the shoulder heading. Other sub-section headings within the main headings may be used but should be limited. The first page should include: title, first and last name of the authors and their affiliations, short title (no more than 20 letters), key words (5 - 8), and the address for correspondence. This file should be designated as 'Title Page (not for review)' when uploading on Manuscript Central.
Abstract:
An abstract not exceeding 200 words should state what was done, the main findings, and how the work was interpreted.
Style:
Abbreviations and symbols must be standard and SI units used throughout. Statistical analyses must explain the methods used. The use of footnotes is not permitted. Single quotation marks should be used.
The Editor reserves the right to alter manuscripts whenever necessary to make them conform to the stylistic and bibliographic conventions of the journal.
References:
References should follow the CBE Citation & Sequence format. Only works actually cited in the text should be included in the references. Indicate in the text with Arabic numbers inside square brackets. Spelling in the reference list should follow the original. References should then be listed in numerical order at the end of the article. Examples are provided as follows:
Journal article: [1] Steiner U, Klein J, Eiser E, Budkowski A, Fetters LJ. Complete wetting from polymer mixtures. Science 1992;258:1122-9.
Book chapter:
[2] Kuret JA, Murad F. Adenohypophyseal hormones and related substances. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. The pharmacological basis of therapeutics. 8th ed. New York: Pergamon; 1990. p 1334-60.
Conference proceedings:
[3] Irvin AD, Cunningham MP, Young AS, editors. Advances in the control of Theileriosis. International Conference held at the International Laboratory for Research on Animal Diseases; 1981 Feb 9-13; Nairobi. Boston: Martinus Nijhoff Publishers; 1981. 427 p.
Dissertations or Thesis:
[4] Mangie ED. A comparative study of the perceptions of illness in New Kingdom Egypt and Mesopotamia of the early first millennium [dissertation]. Akron (OH): University of Akron; 1991. 160 p. Available from: University Microfilms, Ann Arbor MI; AAG9203425.
Webpage:
[6] British Medical Journal [Internet]. Stanford, CA: Stanford Univ; 2004 July 10 - [cited 2004 Aug 12]; Available from:
http://bmj.bmjjournals.com/ Internet databases:
[7] Prevention News Update Database [Internet]. Rockville (MD): Centers for Disease Control and Prevention (US), National Prevention Information Network. 1988 Jun - [cited 2001 Apr 12]. Available from:
www.cdcnpin.org/db/public/dnmain.htm Acknowledgements:
The scientific and material contributions of others to the work should be acknowledged. Any grant supports should be listed and permission for reproduction of published material acknowledged.
Illustrations:
Digital images are necessary. Files should be saved as one of the following formats: TIFF, JPG, PostScript or EPS, and should contain all the necessary font information and the source file of the application (e.g. CorelDraw/Mac, CorelDraw/PC).The use of symbols in illustrations should be consistent with usage within the paper. All illustrations should be numbered as figures whether they are photographs, representational drawings or graphs. Legends for illustrations should be collected together and presented on a separate manuscript page. All illustrations should be specifically referred to in the text, e.g., Figure 2. Avoid the use of colour and tints for purely aesthetic reasons. Authors will be expected to defray the extra cost of printing any illustration in colour (details on request).
Colour Figures: Any figure submitted as a colour original will appear in colour in the journal's online edition free of charge and can be downloaded. Paper copy colour reproduction will only be considered on condition that authors contribute to the associated costs. Charges are: 500/US$1030 for the first colour page and 250/US$515 for each colour page after per article. (Colour costs will be waived for invited Review Articles)
Tables:
Tables ideally should not have more than 80 characters to the line (counting spaces between columns as 4 characters) unless absolutely unavoidable. Each table should be on a separate page with its caption. The following symbols should be used for notes All tables should be specifically referred to in the text, e.g., Table 3.
Proofs:
The designated author will receive copies of the proofs, which should be read carefully for errors. The corrected proof must be returned promptly. Authors will be asked to defray the expense of any major alterations to the proofs which are departures from the original copy.
Offprints and Reprints:
Offprints and reprints of articles published in this journal can be purchased once the article has been published online. Corresponding authors will receive free online access to their article through our website. Reprints of articles published in this journal can be purchased through Rightslink® when proofs are received. Copies of the Journal can be purchased at the authors' preferential rate of 15.00/$25.00 per copy.
Books for Review:
Should be sent to: Astrid Pascal, Managing Editor, Groningen University Hospital, Hanzeplein 1, 9713 GZ Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands.
NIH PUBLIC ACCESS POLICY
In consideration of the National Institutes of Health (NIH) Public Access Policy, Informa Healthcare acknowledges that the broad and open dissemination of NIH-funded research results may benefit future scientific and medical research. Because we value the current and future contributions that our journals make to the scientific body of knowledge, we have made certain that our policies accommodate those authors who wish to submit to PubMed Central.
Informa Healthcare's position with respect to public access to NIH-funded work published in Informa Healthcare journals is as follows:
• Informa Healthcare authors may voluntarily submit their funded work to PubMed Central after a 12-month embargo period;
• 'Funded work' shall be defined as the final, peer-reviewed manuscript that is accepted by the Editor-in-Chief of the journal. This manuscript must not be altered by Publisher's copyediting and typesetting services; and
• This embargo period begins the day the work is published online on our website.
Recommend
Mark
Alert
Link
Print
